Background illustration for clinical trials search

Paid Clinical Trials Ogden

Discover 1,068 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

for
Urothelial Carcinoma
Location: Salt Lake City UT, Orange CA, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05562830

Phase1, Phase2, Recruiting
Active & Responsive

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

for
Bladder Cancer
Location: Salt Lake City UT, San Francisco CA, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07232602

Phase1, Phase2, Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Salt Lake City UT, Palo Alto CA, Los Angeles CA,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase2, Recruiting
Active & Responsive

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

for
Lymphoma, Myeloma, Cytokine Release Syndrome,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 21+

Code: NCT07390071

Recruiting
Active & Responsive

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

for
Breast Cancer Female, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Female

Age: 18+

Code: NCT07120100

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

for
Prostate Cancer, Metastatic Prostate Cancer,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 21+

Code: NCT07032584

Recruiting
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: Salt Lake City UT, Seattle WA, Houston TX,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Salt Lake City UT, Billings MT, Aurora CO, Phoenix AZ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Salt Lake City UT, Longmont CO, Reno NV, Sacramento CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

for
Lymphoblastic Leukemia
Location: Salt Lake City UT, Madera CA, Phoenix AZ,
Sponsor: Tanja Andrea Gruber

Sex: All

Age: 0 - 1

Code: NCT05848687

Phase1, Phase2, Recruiting
Active & Responsive

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

for
Advanced Melanoma
Location: Salt Lake City UT, Phoenix AZ, Seattle WA, Vancouver,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT05549297

Phase3, Recruiting
Active & Responsive

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

for
Glioblastoma
Location: Salt Lake City UT, Aurora CO, Los Angeles CA, Orange CA,
Sponsor: Global Coalition for Adaptive Research

Sex: All

Age: 18+

Code: NCT03970447

Phase2, Phase3, Recruiting
Active & Responsive

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for
HIV-1-infection
Location: Salt Lake City UT, Denver CO, Sante Fe NM,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07645287

Phase2, Recruiting
Active & Responsive

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

for
Overweight, Obesity, Overweight and/or Obesity,
Location: Salt Lake City UT, Butte MT, Las Vegas NV,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07575932

Phase2, Recruiting
Active & Responsive

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

for
Healthy
Location: Salt Lake City UT, Idaho Falls ID, Rexburg ID, Boise ID,
Sponsor: Pfizer

Sex: All

Age: 0 - 49

Code: NCT07160244

Phase3, Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Salt Lake City UT, Palo Alto CA, Los Angeles CA,
Sponsor: Dyne Therapeutics

Sex: All

Age: 16+

Code: NCT07486934

Phase3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Salt Lake City UT, Boise ID, Albuquerque NM,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase3, Recruiting
Active & Responsive

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

for
Autoimmune Diseases, Epilepsy, Autonomic Dysfunction,
Location: Salt Lake City UT, Louisville KY
Sponsor: University of Louisville

Sex: All

Age: 0 - 60

Code: NCT03953768

Recruiting
Active & Responsive

Gastroschisis Outcomes of Delivery (GOOD) Study

for
Gastroschisis
Location: Salt Lake City UT, Aurora CO, Loma Linda CA,
Sponsor: Medical College of Wisconsin

Sex: Female

Age: 18+

Code: NCT02774746

Recruiting
Active & Responsive

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

for
Neuroblastoma, Sarcoma
Location: Salt Lake City UT, Aurora CO, Birmingham AL,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 40

Code: NCT05135975

Phase2, Recruiting